Scientists Discover New Target for Personalized Cancer Therapy

A novel method developed by scientists was found to disrupt the tumor growth signaling pathway, with findings that suggest a new treatment for breast, colon, melanoma and other cancers.

The research team has pinpointed the cancer abnormality to a mutation in a gene called PIK3CA that results in a mutant protein, which may be an early cancer switch. By disrupting the mutated signaling pathway, the Case Western Reserve team, led by John Wang, PhD, inhibited the growth of cancer cells, opening the possibility to new cancer therapies.

Breast Cancer Screening using Mammogram
Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.

Cancer arises from a single cell, which has mutated in a small number of genes because of random errors in the DNA replication process. These mutations play key roles in carcinogenesis.

"This discovery has a broad impact on the treatment of human cancer patients because so many cancers are affected by this particular mutation in the p110a protein, which is encoded by the PIK3CA gene," said Wang, an associate professor in the Department of Genetics and Case Comprehensive Cancer Center.

"This is a significant advance because we can now disrupt this misdirected signaling pathway in cancer cells," the researcher added.

Quiz on Breast Cancer
Breast cancer is one of the leading causes of cancer deaths among women. It is often said that a woman who breast-feeds is at a lower risk of developing cancer compared to another who does not .Are these mere old wives tales or is there some truth in it? This quiz on breast cancer has all the details.

"If you turn on a light, you have to turn on a switch. But in the case of the mutation of this protein, p110a turns on by itself," Wang explained.

"The mutation rewires the circuit and is uncontrolled. This implies that if you break these wires, you can control the growth of cancer. Our current discovery may lead to finding less toxic drugs that can be used for personalized treatment for cancer patients in the future," he added.

Study Links Skin Cancer to Future Risk of Other Cancers
White people who have non-melanoma skin cancer (types of skin cancer other than melanoma) be at increased risk of having other forms of cancer in the future, a new study reveals.

This research will impact the field by focusing us on new targets for treating and preventing metastasis in patients in a many different types of human cancers, noted Stanton Gerson, MD, Asa and Patricia Shiverick-Jane Shiverick (Tripp) Professor of Hematological Oncology, and director of Case Comprehensive Cancer Center and of Seidman Cancer Center at University Hospitals Case Medical Center.

Their findings were published in the journal Cancer Cell.

Tumor Growth in Mice Slowed Down Through Injection of Human Stem Cells
A new study published in the journal Stem Cell Research & Therapy found that tumor growth in mice could be slowed down by injecting human stem cells into the mice.

Source-ANI